Literature DB >> 29904456

Brockenbrough-Braunwald-Morrow Sign: An Evaluative Hemodynamic Maneuver for Left Ventricular Outflow Tract Obstruction.

Glenmore Lasam1.   

Abstract

A case of a 77-year-old woman with a history of hypertrophic cardiomyopathy (HCM) presented with intermittent episodes of exertional dyspnea and chest discomfort. Her coronary angiogram revealed normal coronary arteries but with hypertrophic obstructive cardiomyopathy with an increasing left ventricular-aortic gradient on isoproterenol provocation. Likewise, an intensified gradient was observed after a premature ventricular contraction (PVC) that is distinguished as the Brockenbrough-Braunwald-Morrow sign substantiating confirmation of left ventricular outflow tract (LVOT) obstruction.

Entities:  

Keywords:  Arterial pulse pressure; Brockenbrough-Braunwald-Morrow sign; Hemodynamic maneuver; Left ventricular outflow tract obstruction; Left ventricular systolic pressure; Premature ventricular contraction

Year:  2018        PMID: 29904456      PMCID: PMC5997442          DOI: 10.14740/cr676w

Source DB:  PubMed          Journal:  Cardiol Res        ISSN: 1923-2829


Introduction

Hypertrophic cardiomyopathy (HCM) presents with left ventricular outflow tract (LVOT) obstruction culminating into syncope, angina and heart failure symptoms. An evaluative hemodynamic maneuver, Brockenbrough-Braunwald-Morrow Sign, can provide a hint to the existence and degree of LVOT obstruction.

Case Report

A 77-year-old woman with a history of HCM, hypertension, and hyperlipidemia presented to her cardiologist because of intermittent episodes of exertional dyspnea and chest discomfort. She has been on anti-ischemic treatment but did not improve her symptoms. She was eventually scheduled for an elective cardiac catheterization which showed normal coronary arteries, mild pulmonary hypertension, elevated pulmonary capillary wedge and left ventricular end diastolic pressures, and hypertrophic obstructive cardiomyopathy (HOCM) with an increasing left ventricular-aortic gradient on isoproterenol challenge. A left ventricular and aortic pressure gradient was absent at rest (Fig. 1), but was recognized during isoproterenol administration (Fig. 2). Also, an intensified gradient was observed after a premature ventricular beat (Fig. 2) that is characterized as the Brockenbrough-Braunwald-Morrow sign establishing evidence of LVOT obstruction.
Figure 1

Concurrent measurement at rest of left ventricular and aortic pressures on a gradation of 0 to 200 mm Hg demonstrating an absence of left ventricular outflow tract gradient.

Figure 2

Concurrent measurement of left ventricular and aortic pressures after isoproterenol administration exhibiting evidence of 120 mm Hg gradient (blue oval at lower panel). Also, an intensified left ventricular-aortic gradient (red oval at lower panel) was noted after premature ventricular contraction (green oval at upper panel).

Concurrent measurement at rest of left ventricular and aortic pressures on a gradation of 0 to 200 mm Hg demonstrating an absence of left ventricular outflow tract gradient. Concurrent measurement of left ventricular and aortic pressures after isoproterenol administration exhibiting evidence of 120 mm Hg gradient (blue oval at lower panel). Also, an intensified left ventricular-aortic gradient (red oval at lower panel) was noted after premature ventricular contraction (green oval at upper panel). Based on the results of coronary angiography with hemodynamic evaluation, the patient was advised to undergo either septal alcohol ablation or surgical myomectomy to abate her symptoms attributed from the HOCM.

Discussion

Brockenbrough-Braunwald-Morrow sign has been conceptualized when a paradoxical decline in arterial pulse pressure and a concomitant rise in left ventricular systolic pressure were noted post premature ventricular contraction beat [1]. A compensatory pause ensues following a premature ventricular contraction (PVC) which increases the filling time during diastole, subsequently, expands the diastolic volume. The Frank-Starling mechanism posits that the stroke volume increases as a result of an increase in end diastolic volume when all factors remain constant [2]. Consequently, the expanded end diastolic volume increases cardiac muscle stretch resulting in an increase in myocardial contractility. Extracellular calcium enters the cardiomyocytes during extrasystole, accumulates in the sarcoplasmic reticulum, and significantly contributes during post extrasystolic contraction [3]. The augmented inotropic response following a PVC aggravates obstruction of the LVOT precipitating a drop in arterial pulse pressure and elevation of left ventricular systolic pressure [4]. Hemodynamic maneuver in the catheterization laboratory utilizes the isoproterenol to document the worsening of the LVOT obstruction in patients with HCM which was evident with this patient. Nethalide, a beta blocker has been used to reverse the effect of isoproterenol which evolutionized the use of beta blockers as the initial treatment of choice in HCM especially those patients with angina [5-7]. Also, an echocardiographic case of intermittent LVOT obstruction had been reported following a premature atrial contraction described as systolic anterior motion of the anterior mitral valve leaflet with prolonged systolic septal contact, dynamic LVOT obstruction, and significant mitral regurgitation which were not evident during the preceding contraction [8]. Brockenbrough-Braunwald-Morrow sign is a beneficial catheterization laboratory maneuver that can be utilized in patients with substantial symptoms and has an exertional gradient not seen at rest [9]. HOCM patients with no documented gradient at rest are around 75%, and the maneuver can be employed to note the severity of dynamic LVOT obstruction in perioperative alcohol septal ablation [10] as well as to confirm the abolition of subaortic obstruction post procedure [11].

Conclusion

The utilization of the hemodynamic maneuver, Brockenbrough-Braunwald-Morrow sign, is an essential evaluative modality in HCM patients with dynamic LVOT obstruction.
  9 in total

1.  EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS.

Authors:  D C HARRISON; E BRAUNWALD; G GLICK; D T MASON; C A CHIDSEY; J ROSS
Journal:  Circulation       Date:  1964-01       Impact factor: 29.690

2.  Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy.

Authors:  G Cherian; I F Brockington; P M Shah; C M Oakley; J F Goodwin
Journal:  Br Med J       Date:  1966-04-09

3.  Echocardiographic Brockenbrough-Braunwald-Morrow sign.

Authors:  Salim Adawi; Ihab Asmer; Amnon Merdler; Avinoam Shiran
Journal:  Eur J Echocardiogr       Date:  2010-10-30

4.  Alcohol septal ablation and the Brockenbrough-Braunwald phenomenon.

Authors:  Chao Y Soon; John M Buergler
Journal:  Catheter Cardiovasc Interv       Date:  2008-12-01       Impact factor: 2.692

5.  Images in clinical medicine. Pressure tracings in obstructive cardiomyopathy.

Authors:  S G Pollock
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

Review 6.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

Authors:  E D Wigle; H Rakowski; B P Kimball; W G Williams
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

Review 7.  Hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

8.  The Brockenbrough-Braunwald-Morrow sign.

Authors:  Alejandro R Trevino; John Buergler
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

9.  The heart extrasystole: an energetic approach.

Authors:  F D Marengo; M T Márquez; P Bonazzola; J E Ponce-Hornos
Journal:  Am J Physiol       Date:  1999-01
  9 in total
  1 in total

1.  Hypertrophic Cardiomyopathy and the Brockenbrough-Braunwald-Morrow Phenomenon: A Case Report.

Authors:  Alexa Bello; Jose L Diaz; Taylor P Travis; Joseph Varon; Salim R Surani
Journal:  Cureus       Date:  2019-10-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.